EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exploring the Endocrine Mechanisms in Adenomyosis: From Pathogenesis to Therapies

Juliette d’Otreppe, Daniel Patino-García, Patryk Piekos, Matthieu de Codt, Diego D. Manavella, Guillaume E. Courtoy, Renan Orellana

Endocrines · 01.02.2024 · 5 (1) · 46-71

DOI: 10.3390/endocrines5010004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrines, online erschienen am 01.02.2024. Verfasst von Juliette d’Otreppe und 6 weiteren Autor:innen. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 176 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Researcher Incentive Program (PRONII) of the Paraguayan National Council for Research and Technology (CONACYT).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Adenomyosis (ADM) is a multifaceted uterine pathology characterized by the ectopic infiltration of endometrial tissue into the myometrium, affecting approximately 20% of women in the reproductive age group seeking gynecological care. This condition manifests as a range of debilitating symptoms, including dysmenorrhea, menorrhagia, impaired fertility, and heightened susceptibility to miscarriage and obstetric complications. Substantial research has been dedicated to exploring its underlying molecular mechanisms and developing non-invasive precision medical therapies. ADM is primarily characterized by a dysregulation in sex steroid hormone homeostasis, particularly estrogen and progesterone. However, emerging evidence suggests that additional endocrine mediators and disruptors may play contributory roles in the etiology of ADM. Genetic and epigenetic alterations of endocrine signaling pathways have been implicated as prevailing mechanisms underlying the development and progression of the disease. The present review aims to provide an updated and comprehensive overview of the current understanding of the pathophysiology of ADM, with a particular emphasis on the dysregulated hormonal milieu and the potential involvement of endocrine disruptors. By elucidating these intricate molecular mechanisms, this review seeks to pave the way for novel research directions in the development of targeted therapeutic strategies for ADM management.

Förderung

  • National Researcher Incentive Program (PRONII) of the Paraguayan National Council for Research and Technology (CONACYT)

Zitieren

APA

d’Otreppe, J., Patino-García, D., Piekos, P., Codt, M. D., Manavella, D. D., Courtoy, G. E., & Orellana, R. (2024). Exploring the Endocrine Mechanisms in Adenomyosis: From Pathogenesis to Therapies. Endocrines, 5(1), 46-71. https://doi.org/10.3390/endocrines5010004

Vancouver

d’Otreppe J, Patino-García D, Piekos P, Codt MD, Manavella DD, Courtoy GE, et al. Exploring the Endocrine Mechanisms in Adenomyosis: From Pathogenesis to Therapies. Endocrines. 2024;5(1):46-71. doi:10.3390/endocrines5010004

BibTeX
@article{dOtreppe2024,
  author = {d’Otreppe, Juliette and Patino-García, Daniel and Piekos, Patryk and Codt, Matthieu de and Manavella, Diego D. and Courtoy, Guillaume E. and Orellana, Renan},
  title = {Exploring the Endocrine Mechanisms in Adenomyosis: From Pathogenesis to Therapies},
  journal = {Endocrines},
  year = {2024},
  volume = {5},
  number = {1},
  pages = {46--71},
  doi = {10.3390/endocrines5010004}
}
Kostenlos starten →